Category : Search result: pharmaceutical industry Punjab


Punjab CM Bhagwant Mann Seeks Korean Investment

Punjab Chief Minister Bhagwant Mann meets Indian Ambassador in Seoul, outlines vision for collaboration in agri-tech, defence & infra. Delegation to engage with major Korean firms.

Punjab CM Bhagwant Mann's Investment Pitch in Osaka

Punjab Chief Minister Bhagwant Mann held a business roadshow in Osaka, Japan, inviting investment in key sectors like agriculture, IT, and manufacturing. Discover his vision for transforming Punjab into an industrial hub.

Japanese firm Toppan invests Rs 400 crore in Punjab

Japanese firm Toppan Speciality Films signs Rs 400 crore investment pact with Punjab, plans a skilling centre. CM Bhagwant Mann announces deal during Japan visit ahead of 2026 Investors' Summit.

Punjab brick kilns face extinction amid rising taxes

Punjab's brick kiln industry shrinks from 2,700 to 1,500 units in 3 years. A triple burden of 18% GST on coal, soaring mining royalty & tech upgrades threatens rural jobs & hikes brick prices. Read more.

Punjab Cabinet Nods 300 Specialist Doctors

Punjab cabinet approves empanelment of 300 specialist doctors, new border area incentives, GPS mining vehicle tracking & revised tender limits to boost public services.

Congress Losing Ground to AAP in Punjab

Congress faces mounting challenges in Punjab as AAP gains momentum. Key leaders defect, organizational structure weakens. Can Congress recover before elections?

Lincoln Pharma Aims for Rs 1000 Crore Revenue

Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.

AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion

British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.

Novo Nordisk Profit Drops 27%, Cuts 9,000 Jobs

Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.

Page 2 of 4